Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Brain Innate Immunity In The Regulation Of Neuroinflammation: Therapeutic Strategies By Modulating Cd200-Cd200r Interaction Involve The Cannabinoid System.
Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery disease.
Associations between Proprioceptive Neural Pathway Structural Connectivity and Balance in People with Multiple Sclerosis.
Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.
Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy.
Rare Inflammatory Diseases of the White Matter and Mimics of Multiple Sclerosis and Related Disorders.
[Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis.]
Daclizumab for relapsing remitting multiple sclerosis.
Bi-exponential diffusion signal decay in normal appearing white matter of multiple sclerosis.
Resting-state connectivity of pre-motor cortex reflects disability in multiple sclerosis.
Cognitive reserve and cortical atrophy in multiple sclerosis: A longitudinal study.
ZOCOR (simvastatin) Tablets
Evaluating Neurocognitive Deficits in Patients with Multiple Sclerosis via a Brief Neuropsychological Approach.
HLA-DRB1 does not have a role in clinical response to interferon-beta among Iranian multiple sclerosis patients.
Hematopoietic mobilization: Potential biomarker of response to natalizumab in multiple sclerosis.
Novel serum autoantibodies against talin1 in multiple sclerosis: Possible pathogenetic roles of the antibodies.
Laquinimod, a once-daily oral drug in development for the treatment of relapsing-remitting multiple sclerosis.
CNS response to a second pro-inflammatory event depends on whether the primary demyelinating lesion is active or resolved.
Case report: an orofacial pain patient with spots on the brain-multiple sclerosis versus central systemic lupus erythematosus.
Immunomodulatory effects of helminths and protozoa in multiple sclerosis and experimental autoimmune encephalomyelitis.
Correlation analysis of visual analogue scale and measures of walking ability in multiple sclerosis patients.
A facilitation and co-ordination therapy approach to the treatment of multiple sclerosis.
The role of iron in brain ageing and neurodegenerative disorders.
Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up.
Cognitive function in multiple sclerosis: a subcortical pattern of neuropsychological impairment?

Pages